Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Recognised Researcher (R2) Country Sweden Application Deadline 13 Jan 2026 - 22:59 (UTC) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not
-
recent or soon-to-be-completed PhD (within the last 0-5 years) in Materials Science, Computational Materials Science, Chemical Engineering or a closely related field. 2. Technical Expertise
-
combines multimodal neuroimaging with computational modeling to characterize the neural mechanisms underlying human social decision making. The focus of this project will be to unravel the neurocomputational
-
(or be close to completing) a PhD in Computer Science, Machine Learning, Natural Language Processing (NLP), or a related field, with a thesis focused on AI, specifically LLMs. The candidate will apply
-
in international conferences and journals. Your profile The ideal applicant should possess a PhD in Mechanical Engineering or a closely related field. It is anticipated that applicants will bring
-
This 36-month postdoctoral position is part of the project ENLIGHT (Enabling a Lifecycle Approach to Graphite for Advanced Modular Reactors) consortium, a £13.2 million, five-year programme
-
through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description As part of the ANR Bactoclot project
-
, including robotic control, mechanics of materials, fluid mechanics and biological systems, in collaboration with other researchers and companies. Your profile Applicants should hold a PhD in Computer
-
mechanisms of functional nucleic acids and the various proteins that interact with them. This multidisciplinary research environment integrates concepts from biology, chemistry, physics, computer science, and
-
Clinical Cooperation Unit (headed by Prof. Dr. med. Johannes Betge) aims to identify cancer vulnerabilities and uncover mechanisms of treatment resistance by using patient-derived cancer models and high